Neurometrix Inc (NASDAQ:NURO) gapped up prior to trading on Friday . The stock had previously closed at $2.01, but opened at $2.07. Neurometrix shares last traded at $2.08, with a volume of 2192100 shares changing hands.
A number of equities research analysts recently commented on the company. ValuEngine upgraded Neurometrix from a “strong sell” rating to a “sell” rating in a report on Tuesday, December 26th. HC Wainwright reiterated a “buy” rating and issued a $3.00 price objective (down previously from $10.00) on shares of Neurometrix in a report on Friday, October 20th.
The firm has a market capitalization of $4.20, a price-to-earnings ratio of -0.11 and a beta of 0.32.
ILLEGAL ACTIVITY NOTICE: “Neurometrix (NURO) Shares Gap Up to $2.07” was reported by Ticker Report and is the sole property of of Ticker Report. If you are reading this report on another domain, it was illegally copied and republished in violation of U.S. and international copyright & trademark legislation. The correct version of this report can be read at https://www.tickerreport.com/banking-finance/3148426/neurometrix-nuro-shares-gap-up-to-2-07.html.
Neurometrix Company Profile
NeuroMetrix, Inc is a healthcare company combining bioelectrical and digital medicine to address chronic health conditions, including chronic pain, sleep disorders and diabetes. The Company is engaged in the sale of medical equipment, and consumables and accessories. It has two principal product lines: Wearable neuro-stimulation therapeutic devices and Point-of-care neuropathy diagnostic tests.
Receive News & Ratings for Neurometrix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neurometrix and related companies with MarketBeat.com's FREE daily email newsletter.